ProMeta: Few-shot PROTAC-targeted degradation prediction across E3 ligases

arXiv:2609. 09891v1 Announce Type: cross Abstract: Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative therapeutic strategy that selectively degrades historically ''undruggable'' targets via the ubiquitin-proteasome system.